{"database": "openregs", "table": "documents", "rows": [["FDA-2012-N-0002-0010", "FDA", "FDA-2012-N-0002", "New Animal Drugs: Ceftiofur Sodium; Lincomycin Powder; Naracin; Tylosin", "Rule", "Final Rule", "2012-05-17T04:00:00Z", 2012, 5, null, null, "2012-05-17T13:34:00Z", "2012-11937", 0, 0, "090000648101233c"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2012-N-0002-0010"], "units": {}, "query_ms": 0.5164868198335171, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}